Scorr-Insert
X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Limaprost Alfadex

            Therapeutic Area: Neurology

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Nichi-Iko Pharmaceutical

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Licensing Agreement March 05, 2020

            Details:

            Nichi-Iko will convert the formulation of “Limaprost Alfadex tablets 5 µg to a formulation which has been improved for moisture resistance stability following the technology transfer.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Caffeine,Isometheptene,Metamizole Sodium

            Therapeutic Area: Neurology

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Hypera Pharma

            Deal Size: $825.0 million Upfront Cash: Undisclosed

            Deal Type: Divestment March 02, 2020

            Details:

            The portfolio includes over-the-counter and prescription pharmaceutical products sold in Brazil, Mexico, Argentina, Colombia, Ecuador, Panama and Peru, which are part of Takeda’s Business Unit.